Getting Decentralized Right
What Matters to Patients
In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.
If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.
About Phil Kelly
Phil was diagnosed with bladder cancer almost 11 years ago, and after he completed his active treatment, he drew on the experience to help others. He is actively involved with one of the two bladder cancer charities in the UK, Action Bladder Cancer UK, initially as a trustee and more recently as a patient adviser. He has also been involved in providing one-on-one support for individual bladder cancer patients in different situations and at different stages of their treatment.
Missed Part 1? Click Here to Watch.
